Yonatan Mahller, MD, PhD
Obstetrics & Gynecology
Dr. Yonatan Y. Mahller, MD
|
|
Give Review
Dr. Yonatan Y. Mahller works in the field of Obstetrics & Gynecology. He went to medical school at University of Cincinnati College of Medicine. He has 12 awards "Special Resident in Minimally Invasive Gynecology", "Standing Ovation Award for Patient Care", "Third Place Poster Presentation", "MD/PhD Scholarship Award", "Travel Grant Award", "Graduate Student Award for Exemplary Scholarship in the Life Sciences", "First Place Poster Presentation", "Outstanding Poster Presentation", "Honorable Mention", "Top Poster Presentation", "Top Oral Presentation" and "Travel Award". Yonatan Mahller is a published doctor. He has 14 papers published. The most current publication "Associations between DISC assessment and performance in obstetrics and gynecology residents."
Publications
- Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus.
- Targeting cancer-initiating cells With oncolytic viruses.
- Oncolytic HSV and erlotinib inhibit tumor Growth and angiogenesis in a novel malignant peripheral nerve sheath tumor xenograft model.
- Tissue inhibitor of metalloproteinase-3 via oncolytic herpesvirus inhibits tumor Growth and vascular progenitors.
- Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.
- Associations between DISC assessment and performance in obstetrics and gynecology residents.
- Saposin C coupled lipid nanovesicles enable cancer-selective optical and magnetic resonance imaging.
- Molecular engineering and validation of an oncolytic herpes simplex virus type 1 transcriptionally targeted to midkine-positive tumors.
- Cancer-selective targeting and cytotoxicity by liposomal-coupled lysosomal saposin C protein.
- Efficacy and safety of the oncolytic herpes simplex virus rRp450 alone and combined With cyclophosphamide.
- Malignant peripheral nerve sheath tumors With high and low Ras-GTP are permissive for oncolytic herpes simplex virus mutants.
- Oncolytic herpes simplex virus mutants are more efficacious than wild-type adenovirus Type 5 for the treatment of high-risk neuroblastomas in preclinical models.
- Widespread intratumoral virus distribution With fractionated injection enables local control of large human rhabdomyosarcoma xenografts by oncolytic herpes simplex vir...
Procedures Preformed
- Birth Control
- C-Section
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- View All
Conditions Treated
- Abnormal Uterine Bleeding
- Breech Position
- Cervical Dysplasia
- Chlamydia Infections
- View All
Doctors Specialties
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Special Resident in Minimally Invasive Gynecology
- Standing Ovation Award for Patient Care
- Third Place Poster Presentation
- MD/PhD Scholarship Award
- Travel Grant Award
- Graduate Student Award for Exemplary Scholarship in the Life Sciences
- First Place Poster Presentation
- Outstanding Poster Presentation
- Honorable Mention
- Top Poster Presentation
- Top Oral Presentation
- Travel Award
Education
-
Cedars-Sinai Medical Center -
University of Cincinnati College of Medicine
Hospital
-
St. Joseph Hospital
Helpful Reviews
Similar Doctors
|
Dr. Tamera Hatfield, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maureen C. Ries, MD
This Doctor is OpenDoctor Recommended.
|